Find Clindamycin Palmitate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

22RELATED EXCIPIENT COMPANIES

41EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

Annual Reports

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Clindamycin palmitate hcl, 25507-04-4, Cleocin pediatric, Clindamycin 2-palmitate hydrochloride, Vn9a8jm7m7, U-25,179 e
Molecular Formula
C34H64Cl2N2O6S
Molecular Weight
699.9  g/mol
InChI Key
GTNDZRUWKHDICY-DJHAJVGHSA-N
FDA UNII
VN9A8JM7M7

Clindamycin Palmitate
Clindamycin Palmitate Hydrochloride is the palmitate hydrochloride form of clindamycin, a semi-synthetic, chlorinated broad spectrum antibiotic produced by chemical modification of lincomycin. Clindamycin palmitate hydrochloride is used for oral suspension.
1 2D Structure

Clindamycin Palmitate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] hexadecanoate;hydrochloride
2.1.2 InChI
InChI=1S/C34H63ClN2O6S.ClH/c1-6-8-9-10-11-12-13-14-15-16-17-18-19-21-27(38)42-32-30(40)29(39)31(43-34(32)44-5)28(24(3)35)36-33(41)26-22-25(20-7-2)23-37(26)4;/h24-26,28-32,34,39-40H,6-23H2,1-5H3,(H,36,41);1H/t24-,25+,26-,28+,29+,30-,31+,32+,34+;/m0./s1
2.1.3 InChI Key
GTNDZRUWKHDICY-DJHAJVGHSA-N
2.1.4 Canonical SMILES
CCCCCCCCCCCCCCCC(=O)OC1C(C(C(OC1SC)C(C(C)Cl)NC(=O)C2CC(CN2C)CCC)O)O.Cl
2.1.5 Isomeric SMILES
CCCCCCCCCCCCCCCC(=O)O[C@@H]1[C@H]([C@H]([C@H](O[C@@H]1SC)[C@@H]([C@H](C)Cl)NC(=O)[C@@H]2C[C@H](CN2C)CCC)O)O.Cl
2.2 Other Identifiers
2.2.1 UNII
VN9A8JM7M7
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 7-chloro-7-deoxylincomycin Palmitate

2. 7-chlorolincomycin Palmitate

3. Cleocin Palmitate

4. Clindamycin Palmitate

2.3.2 Depositor-Supplied Synonyms

1. Clindamycin Palmitate Hcl

2. 25507-04-4

3. Cleocin Pediatric

4. Clindamycin 2-palmitate Hydrochloride

5. Vn9a8jm7m7

6. U-25,179 E

7. 25507-04-4 (palmitate Hcl)

8. Nsc-759141

9. U-25179e

10. U-25179-e

11. Clindamycin Palmitate (hydrochloride)

12. (2r,3r,4s,5r,6r)-6-((1s,2s)-2-chloro-1-((2s,4r)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-2-(methylthio)tetrahydro-2h-pyran-3-yl Palmitate

13. (2r,3r,4s,5r,6r)-6-((1s,2s)-2-chloro-1-((2s,4r)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-2-(methylthio)tetrahydro-2h-pyran-3-yl Palmitate Hydrochloride

14. [(2r,3r,4s,5r,6r)-6-[(1s,2s)-2-chloro-1-[[(2s,4r)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] Hexadecanoate;hydrochloride

15. Unii-vn9a8jm7m7

16. Ncgc00185773-02

17. U 25179e

18. Cleocin Pediatric (tn)

19. Dsstox_cid_28660

20. Dsstox_rid_82930

21. Dsstox_gsid_48734

22. Schembl41416

23. Clindamycin Palmitate Hydrochloride [usan:usp:jan]

24. Chembl1200632

25. Dtxsid3048734

26. Niosh/gf2450000

27. Chebi:34647

28. Hy-b1454

29. Tox21_113175

30. Mfcd09752824

31. Akos030242182

32. Ccg-270385

33. Nsc 759141

34. As-58470

35. Clindamycin-2-palmitate, Monohydrochloride

36. Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-l-2-pyrrolidinecarboxamido)-1-thio-l-threo-alpha-d-galacto-octopyranoside 2-palmitate Monohydrochloride

37. Cas-25507-04-4

38. Cs-0013162

39. Gf24500000

40. Clindamycin Palmitate Hydrochloride (jan/usp)

41. D01990

42. F20748

43. Clindamycin Palmitate Hydrochloride [jan]

44. Clindamycin Palmitate Hydrochloride [mart.]

45. Clindamycin Palmitate Hydrochloride [usan]

46. Clindamycin Palmitate Hydrochloride [vandf]

47. Clindamycin Palmitate Hydrochloride [usp-rs]

48. Clindamycin Palmitate Hydrochloride [who-dd]

49. J-016026

50. Q27291919

51. Clindamycin Palmitate Hydrochloride [orange Book]

52. Clindamycin Palmitate Hydrochloride [usp Monograph]

53. L-threo-.alpha.-d-galacto-octopyranoside, Methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-2-hexadecanoate, Monohydrochloride, (2s-trans)-

54. L-threo-alpha-d-galacto-octopyranoside, Methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-2-hexadecanoate, Monohydrochloride, (2s-trans)-

55. Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-l-2-pyrrolidinecarboxamido)-1-thio-l-threo-.alpha.-d-galacto-octopyranoside 2-palmitate Monohydrochloride

2.4 Create Date
2007-05-07
3 Chemical and Physical Properties
Molecular Weight 699.9 g/mol
Molecular Formula C34H64Cl2N2O6S
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count8
Rotatable Bond Count23
Exact Mass698.3862143 g/mol
Monoisotopic Mass698.3862143 g/mol
Topological Polar Surface Area134 Ų
Heavy Atom Count45
Formal Charge0
Complexity810
Isotope Atom Count0
Defined Atom Stereocenter Count9
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameClindamycin palmitate hydrochloride
Drug LabelClindamycin palmitate hydrochloride is a water soluble hydrochloride salt of the ester of clindamycin and palmitic acid. Clindamycin is a semisynthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent compoun...
Active IngredientClindamycin palmitate hydrochloride
Dosage FormFor solution
RouteOral
Strengtheq 75mg base/5ml
Market StatusPrescription
CompanyLyne; Amneal Pharms; Paddock Labs; Aurobindo Pharma

2 of 2  
Drug NameClindamycin palmitate hydrochloride
Drug LabelClindamycin palmitate hydrochloride is a water soluble hydrochloride salt of the ester of clindamycin and palmitic acid. Clindamycin is a semisynthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent compoun...
Active IngredientClindamycin palmitate hydrochloride
Dosage FormFor solution
RouteOral
Strengtheq 75mg base/5ml
Market StatusPrescription
CompanyLyne; Amneal Pharms; Paddock Labs; Aurobindo Pharma

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Anti-Bacterial Agents

Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)


Protein Synthesis Inhibitors

Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Lincosamide Antibacterial [EPC]; Lincosamides [CS]; Neuromuscular Blockade [PE]; Decreased Sebaceous Gland Activity [PE]

API SUPPLIERS

read-more
read-more

01

Transo-Pharm USA LLC

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF US arrow-down AUDIT
Transo Pharm USA Company Banner

02

Nuray Chemicals Private Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Nuray Chemicals

03

Rochem International Inc

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Rochem

04

Shanghai Minbiotech

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothShanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.

Flag China
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Shanghai Minbiotech CB

05

Pfizer Inc

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

World Drug Safety EU
Not Confirmed
arrow

Pfizer Inc

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
World Drug Safety EU
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

06

Zhejiang Hisoar Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

World Drug Safety EU
Not Confirmed
arrow

Zhejiang Hisoar Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
World Drug Safety EU
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

07

Biocare Pharmaceutical

Turkey

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

World Drug Safety EU
Not Confirmed
arrow

Biocare Pharmaceutical

Turkey

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
World Drug Safety EU
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

08

Yaopharma

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

World Drug Safety EU
Not Confirmed
arrow

Yaopharma

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
World Drug Safety EU
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

09

Aurobindo Pharma Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

World Drug Safety EU
Not Confirmed
arrow

Aurobindo Pharma Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
World Drug Safety EU
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WCInactive-api NDC arrow-down KDMF VMF Others AUDIT
blank

10

Viatris

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

World Drug Safety EU
Not Confirmed
arrow

Viatris

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
World Drug Safety EU
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

Formnext Forum
Not Confirmed

01

Formnext Forum
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2013-10-07

Pay. Date : 2013-09-26

DMF Number : 23436

Submission : 2009-12-31

Status : Active

Type : II

blank

02

Formnext Forum
Not Confirmed

02

Formnext Forum
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2014-03-10

Pay. Date : 2013-09-16

DMF Number : 23974

Submission : 2010-07-06

Status : Active

Type : II

blank

03

Lupin Ltd

India

USDMF

arrow
Formnext Forum
Not Confirmed

03

Lupin Ltd

India
arrow
Formnext Forum
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 23115

Submission : 2009-09-30

Status : Inactive

Type : II

blank

04

Formnext Forum
Not Confirmed

04

Formnext Forum
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2015-01-29

Pay. Date : 2015-01-26

DMF Number : 13412

Submission : 1998-09-01

Status : Active

Type : II

blank

05

Formnext Forum
Not Confirmed

06

Formnext Forum
Not Confirmed

06

Formnext Forum
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2014-10-21

Pay. Date : 2013-08-23

DMF Number : 26791

Submission : 2012-12-30

Status : Active

Type : II

blank

07

Formnext Forum
Not Confirmed

07

Formnext Forum
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2014-06-17

Pay. Date : 2013-09-16

DMF Number : 27276

Submission : 2013-09-22

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

Formnext Forum
Not Confirmed
arrow
arrow
Formnext Forum
Not Confirmed

CLINDAMYCIN PALMITATE HYDROCHLORIDE

NDC Package Code : 65862-545

Start Marketing Date : 2023-11-08

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (50kg/50kg)

Marketing Category : BULK INGREDIENT

blank

02

Formnext Forum
Not Confirmed
arrow
arrow
Formnext Forum
Not Confirmed

CLINDAMYCIN PALMITATE

NDC Package Code : 33656-0004

Start Marketing Date : 2010-11-29

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

03

Formnext Forum
Not Confirmed
arrow
arrow
Formnext Forum
Not Confirmed

CLINDAMYCIN PALMITATE

NDC Package Code : 0009-0063

Start Marketing Date : 2014-07-03

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

04

Formnext Forum
Not Confirmed
arrow
arrow
Formnext Forum
Not Confirmed

CLINDAMYCIN PALMITATE HYDROCHLORIDE

NDC Package Code : 65015-759

Start Marketing Date : 2015-06-30

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

05

Formnext Forum
Not Confirmed
arrow
arrow
Formnext Forum
Not Confirmed

CLINDAMYCIN PALMITATE HYDROCHLORIDE

NDC Package Code : 67321-304

Start Marketing Date : 2020-11-20

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

06

Formnext Forum
Not Confirmed
arrow
arrow
Formnext Forum
Not Confirmed

CLINDAMYCIN PALMITATE HYDROCHLORIDE

NDC Package Code : 67321-303

Start Marketing Date : 2015-02-22

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

07

Formnext Forum
Not Confirmed
arrow
arrow
Formnext Forum
Not Confirmed

CLINDAMYCIN PALMITATE HYDROCHLORIDE

NDC Package Code : 39635-0004

Start Marketing Date : 2022-05-12

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

08

Chongqing Bioland Pharmaceutical Lt...

Country
Formnext Forum
Not Confirmed
arrow

Chongqing Bioland Pharmaceutical Lt...

Country
arrow
Formnext Forum
Not Confirmed

CLINDAMYCIN PALMITATE

NDC Package Code : 79290-0002

Start Marketing Date : 2024-04-10

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

Flag U.S.A
Digital Content Digital Content

Clindamycin Palmitate

About the Company : Transo-Pharm, a fully licensed and certified distributor, specializes in pharmaceutical components for the health and veterinary industries. It offers support to clients throughout...

Transo-Pharm, a fully licensed and certified distributor, specializes in pharmaceutical components for the health and veterinary industries. It offers support to clients throughout the entire API life cycle, from product development through sales. Transo-Pharm serves as a sourcing and regulatory marketing agent for API manufacturers. It aids clients in establishing DMFs and provides GMP consulting. With a dedicated regulatory department, a warehouse, proprietary IPs for API processes, and partnerships with laboratories, Transo-Pharm offers a wide range of services. It operates from its offices in Shanghai, Hong Kong, Singapore, and the US.
Transo Pharm USA Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Flag India
Digital Content Digital Content

Clindamycin Palmitate

About the Company : Established in 2012, Nuray Chemicals Pvt Ltd is an API manufacturer for highly regulated markets. Its manufacturing facility with state-of-the-art R&D is located near Chennai in th...

Established in 2012, Nuray Chemicals Pvt Ltd is an API manufacturer for highly regulated markets. Its manufacturing facility with state-of-the-art R&D is located near Chennai in the Indian state of Tamil Nadu. Nuray’s expertise and experience lie in developing the chemistry requirements of the pharmaceutical industry, including the synthesis of NCEs, impurities, metabolites, method development, advanced intermediates and APIs for commercial launch. With its focus on maintaining the highest levels of quality, reliability and transparency, Nuray has emerged as a trusted partner in the global generic market.
Nuray Chemicals

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Flag U.S.A
Digital Content Digital Content

Clindamycin Palmitate

About the Company : Established in 1994, Rochem is a distributor of pharmaceutical, food, nutritional and animal health ingredients to some of the largest companies in the world. It sources high-quali...

Established in 1994, Rochem is a distributor of pharmaceutical, food, nutritional and animal health ingredients to some of the largest companies in the world. It sources high-quality ingredients manufactured in China. Headquartered in the Hauppauge, New York, Rochem has 16 offices spread across the globe to cater to the needs of its customers. Rochem’s operations are fully cGMP compliant and has been audited by the USFDA as well as several multinational organizations. It also trains and audits its partners to ensure all of their technologies and systems are FDA-compliant.
Rochem

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothShanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.

Flag China
Digital Content Digital Content

Clindamycin Palmitate

About the Company : ​Headquartered in Fengxian District, Shanghai Minbiotech Co., Ltd. is a company specializing in the R&D and production of advanced pharmaceutical intermediates and biological API...

​Headquartered in Fengxian District, Shanghai Minbiotech Co., Ltd. is a company specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square meters of R&D centers in Nantong, Jiangsu and Jinan, Shandong, with more than 13,000㎡ of production sites. While supplying products to customers, the company also provides services such as technology development, technology transfer and technology exchange, aiming to provide customers with comprehensive supply and solutions in the biomedical industry.
Shanghai Minbiotech CB

05

Viatris

U.S.A
Formnext Forum
Not Confirmed
arrow

Viatris

U.S.A
arrow
Formnext Forum
Not Confirmed

Clindamycin Palmitate

About the Company : In November 2020, Viatris was formed through the combination of Mylan and Upjohn, with a mission of empowering people worldwide to live healthier at every stage of life. Viatris (N...

In November 2020, Viatris was formed through the combination of Mylan and Upjohn, with a mission of empowering people worldwide to live healthier at every stage of life. Viatris (NASDAQ: VTRS) is a global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020.
blank

06

Formnext Forum
Not Confirmed
arrow
arrow
Formnext Forum
Not Confirmed

Clindamycin Palmitate

About the Company : Zhejiang Hisoar Pharmaceutical Co., Ltd. is located in Taizhou, Zhejiang. It is an IPO-listed company held by the DanKong Group, which mainly manufactures APIs, Formulations, Fine ...

Zhejiang Hisoar Pharmaceutical Co., Ltd. is located in Taizhou, Zhejiang. It is an IPO-listed company held by the DanKong Group, which mainly manufactures APIs, Formulations, Fine Chemicals, Dyestuffs, and Dyestuff Intermediates. It is one of the top 100 innovative companies in the national pharmaceutical industry. The main product categories are antibiotics, cardiovascular, hypoglycemic, and others, fine chemicals, formulations, dyes, and intermediates. More than 70% of pharmaceutical products are exported, in which Clindamycin series production is in the leading position worldwide.
blank

07

Formnext Forum
Not Confirmed
arrow
arrow
Formnext Forum
Not Confirmed

Clindamycin Palmitate

About the Company : Zhejiang Tiantai Pharmaceutical Co., Ltd. (a company to be listed), established in June 1998, specializes in the research and development of clindamycin hydrochloride, clindamycin ...

Zhejiang Tiantai Pharmaceutical Co., Ltd. (a company to be listed), established in June 1998, specializes in the research and development of clindamycin hydrochloride, clindamycin phosphate, and amphotericin B and other antibiotics and antifungal series of characteristic raw materials, It is one of the main manufacturers of clindamycin hydrochloride and clindamycin phosphate both at home and abroad. The company focuses on the big health industry, and builds traditional specialty APIs, API CDMO & CRO business segments, and synthetic biology drug segments.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

01

Yipinhong Pharmaceutical

Country
arrow
Formnext Forum
Not Confirmed

Yipinhong Pharmaceutical

Country
arrow
Formnext Forum
Not Confirmed

Details : Undisclosed

Product Name : Undisclosed

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

March 15, 2017

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Thickeners and Stabilizers

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Taste Masking

read-more
read-more

Direct Compression

read-more
read-more

Emulsifying Agents

read-more
read-more

Solubilizers

read-more
read-more

Coating Systems & Additives

read-more
read-more

Parenteral

read-more
read-more

Granulation

read-more
read-more

Lubricants & Glidants

read-more
read-more

API Stability Enhancers

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Topical

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Co-Processed Excipients

read-more
read-more

Rheology Modifiers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Regulatory FDF Prices

read-more
read-more

01

Brand Name : CLINDAMYCIN PALMITATE HYDROC...

U.S.A
arrow
Formnext Forum
Not Confirmed

Brand Name : CLINDAMYCIN PALMITATE HYDROC...

U.S.A
arrow
Formnext Forum
Not Confirmed

Clindamycin Palmitate

Dosage Form : FOR SOLUTION;ORAL

Dosage Strength : EQ 75MG BASE/5ML

Price Per Pack :

Published in :

Country : USA

RX/OTC/DISCN : RX

blank

02

Brand Name : CLINDAMYCIN PALMITATE HYDROC...

Israel
arrow
Formnext Forum
Not Confirmed

Brand Name : CLINDAMYCIN PALMITATE HYDROC...

Israel
arrow
Formnext Forum
Not Confirmed

Clindamycin Palmitate

Dosage Form : FOR SOLUTION;ORAL

Dosage Strength : EQ 75MG BASE/5ML

Price Per Pack :

Published in :

Country : USA

RX/OTC/DISCN : RX

blank

03

Brand Name : CLEOCIN

U.S.A
arrow
Formnext Forum
Not Confirmed

Brand Name : CLEOCIN

U.S.A
arrow
Formnext Forum
Not Confirmed

Clindamycin Palmitate

Dosage Form : FOR SOLUTION;ORAL

Dosage Strength : EQ 75MG BASE/5ML

Price Per Pack :

Published in :

Country : USA

RX/OTC/DISCN : RX

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 25507-04-4 / Clindamycin Palmitate API manufacturers, exporters & distributors?

Clindamycin Palmitate manufacturers, exporters & distributors 1

95

PharmaCompass offers a list of Clindamycin Palmitate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Clindamycin Palmitate manufacturer or Clindamycin Palmitate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clindamycin Palmitate manufacturer or Clindamycin Palmitate supplier.

PharmaCompass also assists you with knowing the Clindamycin Palmitate API Price utilized in the formulation of products. Clindamycin Palmitate API Price is not always fixed or binding as the Clindamycin Palmitate Price is obtained through a variety of data sources. The Clindamycin Palmitate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Clindamycin Palmitate

Synonyms

Clindamycin palmitate hcl, 25507-04-4, Cleocin pediatric, Clindamycin 2-palmitate hydrochloride, Vn9a8jm7m7, U-25,179 e

Cas Number

25507-04-4

Unique Ingredient Identifier (UNII)

VN9A8JM7M7

About Clindamycin Palmitate

Clindamycin Palmitate Hydrochloride is the palmitate hydrochloride form of clindamycin, a semi-synthetic, chlorinated broad spectrum antibiotic produced by chemical modification of lincomycin. Clindamycin palmitate hydrochloride is used for oral suspension.

Clindamycin Palmitate Hydrochloride Manufacturers

A Clindamycin Palmitate Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clindamycin Palmitate Hydrochloride, including repackagers and relabelers. The FDA regulates Clindamycin Palmitate Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clindamycin Palmitate Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Clindamycin Palmitate Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Clindamycin Palmitate Hydrochloride Suppliers

A Clindamycin Palmitate Hydrochloride supplier is an individual or a company that provides Clindamycin Palmitate Hydrochloride active pharmaceutical ingredient (API) or Clindamycin Palmitate Hydrochloride finished formulations upon request. The Clindamycin Palmitate Hydrochloride suppliers may include Clindamycin Palmitate Hydrochloride API manufacturers, exporters, distributors and traders.

click here to find a list of Clindamycin Palmitate Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Clindamycin Palmitate Hydrochloride USDMF

A Clindamycin Palmitate Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Clindamycin Palmitate Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Clindamycin Palmitate Hydrochloride DMFs exist exist since differing nations have different regulations, such as Clindamycin Palmitate Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Clindamycin Palmitate Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Clindamycin Palmitate Hydrochloride USDMF includes data on Clindamycin Palmitate Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Clindamycin Palmitate Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Clindamycin Palmitate Hydrochloride suppliers with USDMF on PharmaCompass.

Clindamycin Palmitate Hydrochloride WC

A Clindamycin Palmitate Hydrochloride written confirmation (Clindamycin Palmitate Hydrochloride WC) is an official document issued by a regulatory agency to a Clindamycin Palmitate Hydrochloride manufacturer, verifying that the manufacturing facility of a Clindamycin Palmitate Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Clindamycin Palmitate Hydrochloride APIs or Clindamycin Palmitate Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Clindamycin Palmitate Hydrochloride WC (written confirmation) as part of the regulatory process.

click here to find a list of Clindamycin Palmitate Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.

Clindamycin Palmitate Hydrochloride NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Clindamycin Palmitate Hydrochloride as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Clindamycin Palmitate Hydrochloride API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Clindamycin Palmitate Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Clindamycin Palmitate Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Clindamycin Palmitate Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Clindamycin Palmitate Hydrochloride suppliers with NDC on PharmaCompass.

Clindamycin Palmitate Hydrochloride GMP

Clindamycin Palmitate Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Clindamycin Palmitate Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Clindamycin Palmitate Hydrochloride GMP manufacturer or Clindamycin Palmitate Hydrochloride GMP API supplier for your needs.

Clindamycin Palmitate Hydrochloride CoA

A Clindamycin Palmitate Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Clindamycin Palmitate Hydrochloride's compliance with Clindamycin Palmitate Hydrochloride specifications and serves as a tool for batch-level quality control.

Clindamycin Palmitate Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Clindamycin Palmitate Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Clindamycin Palmitate Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Clindamycin Palmitate Hydrochloride EP), Clindamycin Palmitate Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clindamycin Palmitate Hydrochloride USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty